Q2 2021 Holdings
Filed 2021-08-13 | 14 holdings | $204.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Management, Inc.(CGEM) | Common | 230031106 | $203.8M | 7,913,887 | 99.8% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $60.0K | 2,338,581 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $55.3K | 3,370,982 | 0.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $52.3K | 1,676,087 | 0.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $44.3K | 3,196,707 | 0.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $41.6K | 2,388,011 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $32.8K | 2,377,031 | 0.0% |
| MEI Pharma, Inc. | Common | 552798202 | $28.9K | 10,137,859 | 0.0% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $21.0K | 269,186 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $19.4K | 2,331,534 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $17.8K | 812,794 | 0.0% |
| Merus N.V. | Common | N5749R100 | $14.8K | 700,879 | 0.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $11.4K | 337,291 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $5.3K | 218,027 | 0.0% |